Helleday, Thomas http://orcid.org/0000-0002-7384-092X
Article History
First Online: 17 June 2021
Competing interests
: T.H. is inventor on patents related to targeting DNA damage response and repair, receives royalty from PARP-inhibitor sales, and is a shareholder of Oxcia.